References:
1. Wagener JS, Elkin EP, Pasta DJ, et al. Pulmonary function outcomes
for assessing cystic fibrosis care. J Cyst Fibros .
2015;14(3):376-383. doi:10.1016/j.jcf.2014.11.008
2. Stylemans D, Verbanck S, Vincken S, Vincken W, De Wachter E,
Vanderhelst E. Pulmonary function patterns and their association with
genotype and phenotype in adult cystic fibrosis patients. Acta
Clin Belg . 2019;74(6):386-392. doi:10.1080/17843286.2018.1533716
3. Levine H, Cohen-Cymberknoh M, Klein N, et al. Reversible airway
obstruction in cystic fibrosis: Common, but not associated with
characteristics of asthma. J Cyst Fibros . 2016;15(5):652-659.
doi:10.1016/j.jcf.2016.01.003
4. Bennett WD. Effect of beta-adrenergic agonists on mucociliary
clearance. J Allergy Clin Immunol . 2002;110(6 Suppl):S291-297.
doi:10.1067/mai.2002.129704
5. Wong LB, Miller IF, Yeates DB. Stimulation of ciliary beat frequency
by autonomic agonists: in vivo. J Appl Physiol .
1988;65(2):971-981. doi:10.1152/jappl.1988.65.2.971
6. Wood RE, Wanner A, Hirsch J, Farrell PM. Tracheal mucociliary
transport in patients with cystic fibrosis and its stimulation by
terbutaline. Am Rev Respir Dis . 1975;111(6):733-738.
doi:10.1164/arrd.1975.111.6.733
7. Delavoie F, Molinari M, Milliot M, et al. Salmeterol restores
secretory functions in cystic fibrosis airway submucosal gland serous
cells. Am J Respir Cell Mol Biol . 2009;40(4):388-397.
doi:10.1165/rcmb.2008-0037OC
8. Taouil K, Hinnrasky J, Hologne C, Corlieu P, Klossek J-M, Puchelle E.
Stimulation of beta 2-adrenergic receptor increases cystic fibrosis
transmembrane conductance regulator expression in human airway
epithelial cells through a cAMP/protein kinase A-independent pathway.J Biol Chem . 2003;278(19):17320-17327. doi:10.1074/jbc.M212227200
9. Barry PJ, Flume PA. Bronchodilators in cystic fibrosis: a critical
analysis. Expert Review of Respiratory Medicine .
2017;11(1):13-20. doi:10.1080/17476348.2017.1246358
10. Balfour-Lynn IM, Elborn JS. “CF asthma”: what is it and what do we
do about it? Thorax . 2002;57(8):742-748.
doi:10.1136/thorax.57.8.742
11. Kent BD, Lane SJ, van Beek EJ, Dodd JD, Costello RW, Tiddens HAWM.
Asthma and cystic fibrosis: a tangled web. Pediatr Pulmonol .
2014;49(3):205-213. doi:10.1002/ppul.22934
12. Graham BL, Steenbruggen I, Miller MR, et al. Standardization of
Spirometry 2019 Update. An Official American Thoracic Society and
European Respiratory Society Technical Statement. Am J Respir Crit
Care Med . 2019;200(8):e70-e88. doi:10.1164/rccm.201908-1590ST
13. Enright PL, Lebowitz MD, Cockroft DW. Physiologic measures:
pulmonary function tests. Asthma outcome. Am J Respir Crit Care
Med . 1994;149(2 Pt 2):S9-18; discussion S19-20.
doi:10.1164/ajrccm/149.2_Pt_2.S9
14. Pollak M, Shaw M, Wilson D, Grasemann H, Ratjen F. Bronchodilator
Responsiveness in Children with Cystic Fibrosis and Allergic
Bronchopulmonary Aspergillosis. Eur Respir J . Published online
April 8, 2020. doi:10.1183/13993003.00175-2020
15. Pellegrino R. Interpretative strategies for lung function tests.European Respiratory Journal . 2005;26(5):948-968.
doi:10.1183/09031936.05.00035205
16. Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference
values for spirometry for the 3–95-yr age range: the global lung
function 2012 equations. Eur Respir J . 2012;40(6):1324-1343.
doi:10.1183/09031936.00080312
17. Mellis CM, Levison H. Bronchial reactivity in cystic fibrosis.Pediatrics . 1978;61(3):446-450.
18. Eggleston PA, Rosenstein BJ, Stackhouse CM, Alexander MF. Airway
hyperreactivity in cystic fibrosis. Clinical correlates and possible
effects on the course of the disease. Chest . 1988;94(2):360-365.
doi:10.1378/chest.94.2.360
19. Mitchell I, Corey M, Woenne R, Krastins IR, Levison H. Bronchial
hyperreactivity in cystic fibrosis and asthma. J Pediatr .
1978;93(5):744-748. doi:10.1016/s0022-3476(78)81070-1
20. Matusovsky OS, Kachmar L, Ijpma G, et al. Contractile Properties of
Intrapulmonary Airway Smooth Muscle in Cystic Fibrosis. Am J
Respir Cell Mol Biol . 2019;60(4):434-444. doi:10.1165/rcmb.2018-0005OC
21. Balfour-Lynn IM, Welch K, Smith S. Inhaled corticosteroids for
cystic fibrosis. Cochrane Database Syst Rev . 2019;7:CD001915.
doi:10.1002/14651858.CD001915.pub6
22. Balfour-Lynn IM, Lees B, Hall P, et al. Multicenter randomized
controlled trial of withdrawal of inhaled corticosteroids in cystic
fibrosis. Am J Respir Crit Care Med . 2006;173(12):1356-1362.
doi:10.1164/rccm.200511-1808OC
23. Bruce Marshall, Albert Faro, Alexander Elbert, et al. Cystic
Fibrosis Foundation Patient Registry 2018 Annual Data Report Bethesda,
Maryland.
24. Maturu VN, Agarwal R. Prevalence of Aspergillus sensitization and
allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic
review and meta-analysis. Clin Exp Allergy .
2015;45(12):1765-1778. doi:10.1111/cea.12595